USPTO serial 99794163
LOFT THERAPEUTICS
Reviewed by CopyMark Law Group
Status 641Office Action
- Filing date
- Status date
- Registration date
- —
- Examiner
- ALESKOW, DAVID HOWARD
What this means
The USPTO has issued an Office Action on this application. A response is typically required before the deadline, or the application can be abandoned.
Deadline: Nov 3, 2026
Need help with LOFT THERAPEUTICS?
CopyMark Law Group can help you respond to USPTO correspondence, keep a registration alive, or watch new filings against your mark.
Office Action issues
The USPTO examiner found no conflicting marks, but requires us to add a disclaimer for the descriptive wording 'THERAPEUTICS'.
Owner
Loft Therapeutics Inc
Dover, DE, US
Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders | ACTIVE | — |
Prosecution history
| Date | Code | Event |
|---|---|---|
| Aug 3, 2026 | GNRN | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Aug 3, 2026 | GNRT | NON-FINAL ACTION E-MAILED |
| Aug 3, 2026 | CNRT | NON-FINAL ACTION WRITTEN |
| Jul 23, 2026 | DOCK | ASSIGNED TO EXAMINER |
| Apr 29, 2026 | MAFR | APPLICATION FILING RECEIPT MAILED |
| Apr 29, 2026 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Apr 29, 2026 | NWAP | NEW APPLICATION ENTERED |